Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1058 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Not yet recruiting Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance
Condition: Non-small-cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: pemetrexed or gemcitabine plus carboplatin,;   Drug: bevacizumab
22 Not yet recruiting Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC
Condition: Non-small Cell Lung Cancer
Intervention: Drug: BPI-9016M
23 Not yet recruiting A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions
Condition: Non-Small Cell Lung Cancer (NSCLC)
Intervention: Drug: Lorlatinib
24 Not yet recruiting A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
25 Recruiting Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Conditions: Lung Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Neoplasms;   Lung Diseases;   Adenocarcinoma;   Advanced Solid Tumors
Intervention: Drug: CK-101
26 Not yet recruiting Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Condition: Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Sym004;   Drug: Nivolumab
27 Not yet recruiting Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
Condition: Non-Small Cell Lung Carcinoma
Interventions: Drug: BGB324;   Drug: Docetaxel
28 Not yet recruiting Detection of Circulating Biomarkers of Immunogenic Cell Death
Condition: Non Small Cell Lung Cancer
Intervention: Other: Blood withdrawal
29 Not yet recruiting Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
Conditions: Carcinoma, Non-Small-Cell Lung;   Solid Tumor
Intervention: Drug: Merestinib
30 Not yet recruiting Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Gedatolisib;   Drug: Paclitaxel;   Drug: Carboplatin
31 Recruiting Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression
Conditions: Carcinoma, Non-Small-Cell Lung;   Secondary;   Advanced Stage IIIB;   High Thymidylate Synthase Expression
Interventions: Drug: Oral vinorelbine;   Drug: Cisplatin;   Drug: Maintenance with Metronomic Oral Vinorelbine;   Drug: Pemetrexed;   Drug: Maintenance with Pemetrexed
32 Not yet recruiting Trial of Measles Virotherapy in Combination With Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer
Condition: Recurrent Non-Small Cell Lung Cancer
Interventions: Biological: MV-NIS;   Biological: Nivolumab
33 Not yet recruiting An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: INCB039110;   Drug: Osimertinib
34 Not yet recruiting Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Intervention: Drug: Porfimer sodium
35 Not yet recruiting Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Sevoflurane;   Drug: Propofol
36 Not yet recruiting Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: BPI-15086
37 Not yet recruiting A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: RO7051790
38 Recruiting Suction on Post-Operative Chest Tubes
Condition: Non-small Cell Lung Cancer
Interventions: Device: Suction is set to -2 cmH2O;   Device: Suction is set to -10 cmH2O
39 Recruiting Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy
Condition: Non-Small Cell Lung Cancer
40 Recruiting Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Conditions: Neoplasms;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Bronchial Neoplasms;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Digestive System Neoplasms;   Endocrine Gland Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Lung Diseases;   Breast Diseases;   Renal Neoplasm;   Solid Tumors
Interventions: Drug: Entinostat;   Drug: Pembrolizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years